Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Dermatol Online J ; 22(10)2016 Oct 15.
Article in English | MEDLINE | ID: mdl-28329584

ABSTRACT

We report several scenarios of compromise in patient safety owing to the re-use of mis-assigned patient's surgical instruments in Mohs micrographic surgery.We discuss the breaks in universal protocols that others may experience in their practices and describe corrective measures that our institutions employed to avoid such future events.There is a lack of publication in the literature on the topic of mis-assigned instrument use in Mohs surgery. We believe that the  practice of re-using instruments is cost-effective and therefore common. Based on our humbling experience, this publication may initiate important discussion among dermatologist regarding safety protocols at their respective institutions.


Subject(s)
Cross Infection/prevention & control , Equipment Reuse , Mohs Surgery/instrumentation , Skin Neoplasms/surgery , Surgical Instruments , Time Out, Healthcare/methods , Humans
2.
JAMA Dermatol ; 151(3): 265-70, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25372450

ABSTRACT

IMPORTANCE: Purse-string suture is a closure method that purportedly reduces the scar area compared with second intention healing. Randomized clinical trials comparing these 2 methods appear to be limited or absent. OBJECTIVE: To determine if purse-string suture improves cosmetic outcome, healing time, and scar to defect area compared with second intention healing for circular defects on the trunk and extremities. DESIGN, SETTING, AND PARTICIPANTS: Prospective, 2-arm, randomized, evaluator-blinded clinical trial in a single-center outpatient academic dermatology center. Patients were eligible if they were older than 18 years, able to give informed consent, and had circular or oval postoperative defects larger than 8 mm on the trunk or extremities. INTERVENTIONS: For the purse-string treatment arm, wounds were sewn in circumferential fashion using polydiaxanone suture. Patients in the other treatment arm were allowed to heal by second intent. MAIN OUTCOMES AND MEASURES: The primary outcome measures were the mean total Patient and Observer Scar Assessment Scale (POSAS) scores ascertained from the patient and 2 blinded observers. Secondary outcomes included the ratio of scar to initial defect size, healing time, pain scores, and complication rates. RESULTS: Fifty-two patients were screened, and a total of 44 patients with 50 surgical sites were enrolled. Forty-two patients with 48 surgical sites completed the study. The mean total observer POSAS score was 18.38 for the purse-string group vs 19.91 for the secondary intention group, a nonsignificant difference (P = .41). Similarly, there were no significant differences for any of the following secondary outcome measures: mean total patient POSAS score (P = .96), mean scar-to-defect area (P = .61), and mean pain level at week 1 (P = .19). Statistical trends toward significance were seen in the mean healing time in favor of purse-string suture (P = .10) and scar relief, which favored second intention healing (P = .07). CONCLUSIONS AND RELEVANCE: The purse-string suture results in similar cosmetic outcomes, scar sizes, and pain levels compared with second intention healing for circular or oval wounds on the trunk and extremities. A larger study might better define the potential differences in our secondary outcome measures of healing time and scar relief. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT02062866.


Subject(s)
Cicatrix/pathology , Suture Techniques , Sutures , Wound Healing/physiology , Aged , Female , Humans , Male , Pain/epidemiology , Pain/etiology , Prospective Studies , Single-Blind Method
3.
J Cosmet Dermatol ; 5(3): 268-72, 2006 Sep.
Article in English | MEDLINE | ID: mdl-17177750

ABSTRACT

Botulinum toxin type A is a neurotoxin produced by the bacterium Clostridium botulinum which causes a flaccid muscle paralysis. It has been used extensively in the field of dermatology for the treatment of dynamic rhytides and in the treatment of hyperhidrosis. Botulinum toxin has an excellent safety profile and few side effects when used for these purposes. Recently, botulinum toxin has also been used experimentally in a number of other dermatologic conditions with good results. These conditions include: persistent facial flushing, gustatory sweating and epiphora, anal fissures, familial benign pemphigus (Hailey-Hailey disease), dyshidrotic eczema, and following surgical wound closures. While randomized, controlled prospective trials are still needed to further understand the efficacy and safety of botulinum toxin in these conditions, anecdotal and case report data suggest that botulinum toxin is both safe and efficacious in these and many other procedures.


Subject(s)
Botulinum Toxins, Type A/therapeutic use , Neuromuscular Agents/therapeutic use , Skin Diseases/drug therapy , Administration, Cutaneous , Botulinum Toxins, Type A/administration & dosage , Humans , Neuromuscular Agents/administration & dosage , Wound Healing
SELECTION OF CITATIONS
SEARCH DETAIL
...